Variant report
Variant | esv3367274 |
---|---|
Chromosome Location | chr2:35033798-35035696 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | STAT3 | chr2:35035165-35035293 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM98A-10 | chr2:35034320-35034623 | NONHSAT070053 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SL602P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539868650 | chr2:35033846-35033847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553385538 | chr2:35033883-35033884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573326254 | chr2:35033891-35033892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541954672 | chr2:35033899-35033900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180671184 | chr2:35033907-35033908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369929573 | chr2:35033919-35033920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374662565 | chr2:35033933-35033934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544361928 | chr2:35033944-35033945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs13402513 | chr2:35033964-35033965 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs2259197 | chr2:35033996-35033997 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs539904785 | chr2:35034004-35034005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184202759 | chr2:35034090-35034091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35060085 | chr2:35034093-35034094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372814607 | chr2:35034127-35034128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536324255 | chr2:35034135-35034136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528832086 | chr2:35034137-35034138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548696696 | chr2:35034152-35034153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188531813 | chr2:35034192-35034193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369609237 | chr2:35034226-35034227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551320315 | chr2:35034227-35034228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181666158 | chr2:35034259-35034260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2371735 | chr2:35034260-35034261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553457145 | chr2:35034261-35034262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566849680 | chr2:35034293-35034294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186652904 | chr2:35034298-35034299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192438889 | chr2:35034302-35034303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575622042 | chr2:35034313-35034314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548811022 | chr2:35034339-35034340 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs537718191 | chr2:35034346-35034347 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs557644925 | chr2:35034377-35034378 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs182059607 | chr2:35034378-35034379 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs540039054 | chr2:35034413-35034414 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs72861936 | chr2:35034421-35034422 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs376599621 | chr2:35034424-35034425 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs13018804 | chr2:35034480-35034481 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs573642335 | chr2:35034521-35034522 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs542738170 | chr2:35034556-35034557 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs567337909 | chr2:35034644-35034645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562318869 | chr2:35034676-35034677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554212362 | chr2:35034677-35034678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140346048 | chr2:35034681-35034682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539482523 | chr2:35034688-35034689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187203859 | chr2:35034717-35034718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138438454 | chr2:35034720-35034721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375185451 | chr2:35034722-35034723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117899730 | chr2:35034737-35034738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190818445 | chr2:35034760-35034761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182099036 | chr2:35034798-35034799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112535948 | chr2:35034801-35034802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567088324 | chr2:35034804-35034805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35021200-35035400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:35029600-35046600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:35032600-35033800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr2:35034800-35035000 | Enhancers | Pancreas | Pancrea |
5 | chr2:35034800-35035200 | Enhancers | Gastric | stomach |
6 | chr2:35035000-35041200 | Weak transcription | Pancreas | Pancrea |
7 | chr2:35035200-35039400 | Weak transcription | Gastric | stomach |
8 | chr2:35035400-35036000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr2:35035400-35036000 | Enhancers | Stomach Mucosa | stomach |